RxDoctor Payments DataLook up a doctor →

Megan Collett, APRN

Nurse Practitioner · Lexington, KYNPI 1134580145

Payments from drug & device makers

$13,402in general payments, 2019–2025

Across 640 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$4K
  • AbbVie$3K
  • AstraZeneca$694
  • Biogen$519
  • Pfizer$480
  • Novartis$449
  • plus $5K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.32$3,574
AbbVie(2 entities)212$2,581
AstraZeneca22$694
Biogen29$519
Pfizer50$480
Novartis36$449
Johnson & Johnson(2 entities)20$429
Lilly USA, LLC26$401
Teva Pharmaceuticals USA, Inc.9$278
Eisai Inc.12$266
UCB, Inc.10$225
Bristol Myers Squibb6$213
Alnylam Pharmaceuticals Inc.10$204
Merz Pharmaceuticals, LLC8$188
Argenx US, Inc.10$173
Amgen7$142
SK Life Science, Inc.7$137
Acadia Pharmaceuticals Inc7$132
CSL Behring5$129
Catalyst Pharmaceuticals, Inc.6$126
TG Therapeutics, Inc.7$125
Lundbeck LLC6$111
Boston Scientific5$110
Takeda Pharmaceuticals U.S.A., Inc.5$110
Otsuka America Pharmaceutical, Inc.6$109
Amneal Pharmaceuticals LLC6$104
Neurelis, Inc.6$95
Livanova USA, Inc.4$92
Genentech USA, Inc.6$85
Vanda Pharmaceuticals Inc.3$85
Grifols USA, LLC5$83
Supernus Pharmaceuticals, Inc.4$75
Neurocrine Biosciences, Inc.4$70
Ipsen Biopharmaceuticals, Inc4$62
Sumitomo Pharma America, Inc.4$61
Sunovion Pharmaceuticals Inc.5$60
Octapharma USA, Inc.3$54
Azurity Pharmaceuticals, Inc.3$50
Acorda Therapeutics, Inc3$42
Jazz Pharmaceuticals Inc.2$41
Biohaven Pharmaceutical Holding Company Ltd.2$39
Tanabe Pharma America, Inc.2$38
Tonix Medicines, Inc.2$38
Banner Life Sciences, LLC2$35
Upsher-smith Laboratories LLC2$33
Avion Pharmaceuticals2$31
Sanofi2$30
Almatica Pharma LLC1$25
Scilex Pharmaceuticals Inc.1$22
Harmony Biosciences LLC1$21
Globus Medical1$21
Axsome Therapeutics, Inc.1$20
Cala Health, Inc.1$20
Aucta Pharmaceuticals, Inc.2$18
Avanir Pharmaceuticals, Inc.1$17
GRT US Holding, Inc.1$17
Arbor Pharmaceuticals, Inc.1$16

How this compares

$13,402 in reported general payments places this provider in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky →

Medicare billing

Part B allowed, 2024
$67,589
Medicare patients
163
Services billed
7,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Lexington

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →